Estrogen receptor alpha positive (ERα+) breast cancers constitute the most plentiful breast cancer subtype [1], and metastatic ERα+ tumors result in the majority of patient mortality [2, 3]. This evidence concerns the gene ESR1 and breast carcinoma.